Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$129.64 - $160.7 $977,615 - $1.21 Million
-7,541 Closed
0 $0
Q4 2021

Mar 11, 2022

SELL
$119.87 - $145.67 $36,440 - $44,283
-304 Reduced 3.88%
7,541 $960,000
Q3 2021

Nov 10, 2021

BUY
$128.64 - $184.79 $216,115 - $310,447
1,680 Added 27.25%
7,845 $1.02 Million
Q1 2021

Apr 21, 2021

SELL
$150.19 - $173.5 $42,653 - $49,274
-284 Reduced 4.4%
6,165 $1.01 Million
Q4 2020

Feb 12, 2021

BUY
$140.71 - $165.05 $208,672 - $244,769
1,483 Added 29.86%
6,449 $1.06 Million
Q3 2020

Oct 30, 2020

BUY
$105.46 - $144.13 $23,623 - $32,285
224 Added 4.72%
4,966 $708,000
Q2 2020

Aug 12, 2020

SELL
$95.68 - $121.88 $99,602 - $126,877
-1,041 Reduced 18.0%
4,742 $524,000
Q1 2020

May 13, 2020

BUY
$87.74 - $152.74 $224,175 - $390,250
2,555 Added 79.15%
5,783 $577,000
Q4 2019

Feb 12, 2020

BUY
$117.65 - $153.73 $379,774 - $496,240
3,228 New
3,228 $482,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Bokf, Na Portfolio

Follow Bokf, Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.